Literature DB >> 31279092

Erythrocyte and plasma oxidative stress appears to be compensated in patients with sickle cell disease during a period of relative health, despite the presence of known oxidative agents.

Jon A Detterich1, Honglei Liu2, Silvie Suriany3, Roberta M Kato4, Patjanaporn Chalacheva5, Bruke Tedla2, Payal M Shah6, Michael C Khoo5, John C Wood7, Thomas D Coates6, Ginger L Milne8, Joo-Yeun Oh9, Rakesh P Patel9, Henry Jay Forman10.   

Abstract

Sickle cell disease (SCD) is a monogenetic disease that results in the formation of hemoglobin S. Due to more rapid oxidation of hemoglobin S due to intracellular heme and adventitious iron in SCD, it has been thought that an inherent property of SCD red cells would be an imbalance in antioxidant defenses and oxidant production. Less deformable and fragile RBC in SCD results in intravascular hemolysis and release of free hemoglobin (PFHb) in the plasma, which might be expected to produce oxidative stress in the plasma. Thus, we aimed to characterize intracellular and vascular oxidative stress in whole blood and plasma samples from adult SCD patients and controls recruited into a large study of SCD at Children's Hospital of Los Angeles. We evaluated the cellular content of metHb and several components of the antioxidant system in RBC as well as oxidation of GSH and Prx-2 oxidation in RBC after challenge with hydroperoxides. Plasma markers included PFHb, low molecular weight protein bound heme (freed heme), hemopexin, isoprostanes, and protein carbonyls. While GSH was slightly lower in SCD RBC, protein carbonyls, NADH, NAD+ and total NADP+ + NADPH were not different. Furthermore, GSH or Prx-2 oxidation was not different after oxidative challenge in SCD vs. Control. Elevated freed heme and PFHb had a significant negative, non-linear association with hemopexin. There appeared to be a threshold effect for hemopexin (200 μg/ml), under which the freed heme rose acutely. Plasma F2-isoprostanes were not significantly elevated in SCD. Despite significant release of Hb and elevation of freed heme in SCD when hemopexin was apparently saturated, there was no clear indication of uncompensated vascular oxidative stress. This somewhat surprising result, suggests that oxidative stress is well compensated in RBCs and plasma during a period of relative health.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31279092      PMCID: PMC6750280          DOI: 10.1016/j.freeradbiomed.2019.07.004

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  58 in total

1.  Processing of the lipocalin alpha(1)-microglobulin by hemoglobin induces heme-binding and heme-degradation properties.

Authors:  Maria Allhorn; Tord Berggård; Jonas Nordberg; Martin L Olsson; Bo Akerström
Journal:  Blood       Date:  2002-03-15       Impact factor: 22.113

2.  A specific chemical difference between the globins of normal human and sickle-cell anaemia haemoglobin.

Authors:  V M INGRAM
Journal:  Nature       Date:  1956-10-13       Impact factor: 49.962

3.  Studies on abnormal hemoglobins. VIII. The gelling phenomenon of sickle cell hemoglobin: its biologic and diagnostic significance.

Authors:  K SINGER; L SINGER
Journal:  Blood       Date:  1953-11       Impact factor: 22.113

4.  Studies on the destruction of red blood cells. VIII. Molecular orientation in sickle cell hemoglobin solutions.

Authors:  J W HARRIS
Journal:  Proc Soc Exp Biol Med       Date:  1950-10

5.  Oxygen radical inhibition of nitric oxide-dependent vascular function in sickle cell disease.

Authors:  M Aslan; T M Ryan; B Adler; T M Townes; D A Parks; J A Thompson; A Tousson; M T Gladwin; R P Patel; M M Tarpey; I Batinic-Haberle; C R White; B A Freeman
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

6.  Endothelial dysfunction in patients with sickle cell disease is related to selective impairment of shear stress-mediated vasodilation.

Authors:  L Belhassen; G Pelle; S Sediame; D Bachir; C Carville; C Bucherer; C Lacombe; F Galacteros; S Adnot
Journal:  Blood       Date:  2001-03-15       Impact factor: 22.113

Review 7.  Biologic and pharmacologic regulation of mammalian glutathione synthesis.

Authors:  O W Griffith
Journal:  Free Radic Biol Med       Date:  1999-11       Impact factor: 7.376

8.  A comparison in normal individuals and sickle cell patients of reduced glutathione precursors and their transport between plasma and red cells.

Authors:  K Kiessling; N Roberts; J S Gibson; J C Ellory
Journal:  Hematol J       Date:  2000

9.  Increased F2 isoprostanes in the acute chest syndrome of sickle cell disease as a marker of oxidative stress.

Authors:  E S Klings; B W Christman; J McClung; A F Stucchi; L McMahon; M Brauer; H W Farber
Journal:  Am J Respir Crit Care Med       Date:  2001-10-01       Impact factor: 21.405

10.  Pulmonary hypertension as a risk factor for death in patients with sickle cell disease.

Authors:  Mark T Gladwin; Vandana Sachdev; Maria L Jison; Yukitaka Shizukuda; Jonathan F Plehn; Karin Minter; Bernice Brown; Wynona A Coles; James S Nichols; Inez Ernst; Lori A Hunter; William C Blackwelder; Alan N Schechter; Griffin P Rodgers; Oswaldo Castro; Frederick P Ognibene
Journal:  N Engl J Med       Date:  2004-02-26       Impact factor: 91.245

View more
  6 in total

1.  Tricuspid regurgitant jet velocity and myocardial tissue Doppler parameters predict mortality in a cohort of patients with sickle cell disease spanning from pediatric to adult age groups - revisiting this controversial concept after 16 years of additional evidence.

Authors:  Payal Shah; Silvie Suriany; Roberta Kato; Adam M Bush; Patjanaporn Chalacheva; Saranya Veluswamy; Christopher C Denton; Kelly Russell; Maha Khaleel; Henry J Forman; Michael C K Khoo; Richard Sposto; Thomas D Coates; John C Wood; Jon Detterich
Journal:  Am J Hematol       Date:  2020-10-12       Impact factor: 10.047

Review 2.  The Worst Things in Life are Free: The Role of Free Heme in Sickle Cell Disease.

Authors:  Oluwabukola T Gbotosho; Maria G Kapetanaki; Gregory J Kato
Journal:  Front Immunol       Date:  2021-01-27       Impact factor: 7.561

3.  Effect of Normobaric Hypoxia on Alterations in Redox Homeostasis, Nitrosative Stress, Inflammation, and Lysosomal Function following Acute Physical Exercise.

Authors:  Mateusz Maciejczyk; Anna Zalewska; Małgorzata Gryciuk; Katarzyna Hodun; Miłosz Czuba; Kamila Płoszczyca; Małgorzata Charmas; Jerzy Sadowski; Marcin Baranowski
Journal:  Oxid Med Cell Longev       Date:  2022-02-25       Impact factor: 6.543

4.  Association between NAD+ levels and anaemia among women in community-based study.

Authors:  Fan Yang; Xuguang Zhang; Feifei Hu; Ye Yu; Lei Luo; Xuan Deng; Yuzheng Zhao; Bo Pan; Jinping Zheng; Yugang Qiu; Jun Guo; Feng Xiao; Xiaomei Xie; Zhenyu Ju; Yong Zhou
Journal:  J Cell Mol Med       Date:  2022-04-06       Impact factor: 5.295

Review 5.  Critical Role of Hemopexin Mediated Cytoprotection in the Pathophysiology of Sickle Cell Disease.

Authors:  Rani Ashouri; Madison Fangman; Alicia Burris; Miriam O Ezenwa; Diana J Wilkie; Sylvain Doré
Journal:  Int J Mol Sci       Date:  2021-06-15       Impact factor: 5.923

6.  Influence of Oxidative Stress Biomarkers and Genetic Polymorphisms on the Clinical Severity of Hydroxyurea-Free Senegalese Children with Sickle Cell Anemia.

Authors:  Fatou Gueye Tall; Cyril Martin; El Hadji Malick Ndour; Camille Faes; Indou Déme Ly; Vincent Pialoux; Philippe Connes; Papa Madieye Gueye; Rokhaya Ndiaye Diallo; Céline Renoux; Ibrahima Diagne; Pape Amadou Diop; Aynina Cissé; Philomène Lopez Sall; Philippe Joly
Journal:  Antioxidants (Basel)       Date:  2020-09-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.